Robertson Stephen P. has filed 14 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 36525 shares of Aurinia Pharmaceuticals Inc. ($AUPH) on March 02, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | F | Common Stock | 36525 | $14.21 | 505,861.0000 | 138,959,000 | 6.73% | 0.03% |
| Feb. 27, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 59090 | $0.00 | 542,386.0000 | 138,959,000 | 12.23% | 0.04% |
| Feb. 27, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | A | Employee Stock Option (right to buy) | 98813 | $0.00 | 98,813.0000 | 138,959,000 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | F | Common Stock | 34638 | $14.40 | 483,296.0000 | 138,959,000 | 6.69% | 0.02% |
| Jan. 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 48558 | $0.00 | 557,434.0000 | 138,959,000 | 9.54% | 0.03% |
| Jan. 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | F | Common Stock | 40385 | $15.95 | 517,934.0000 | 138,959,000 | 7.23% | 0.03% |
| Feb. 28, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 84106 | $0.00 | 529,349.0000 | 146,194,000 | 18.89% | 0.06% |
| March 3, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 102406 | $0.00 | 631,755.0000 | 146,194,000 | 19.35% | 0.07% |
| March 3, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 64872 | $8.00 | 566,883.0000 | 146,194,000 | 10.27% | 0.04% |
| March 4, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 57607 | $7.92 | 509,276.0000 | 146,194,000 | 10.16% | 0.04% |
| Feb. 28, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | A | Employee Stock Option (right to buy) | 128438 | $0.00 | 128,438.0000 | 146,194,000 | 9999.99% | 0.09% |
| March 6, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 57745 | $5.60 | 443,824.0000 | 143,236,000 | 11.51% | 0.04% |
| Feb. 20, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 194230 | $0.00 | 501,569.0000 | 143,236,000 | 63.20% | 0.14% |
| March 2, 2023 | Aurinia Pharmaceuticals Inc. | $AUPH | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 19644 | $8.78 | 303,122.0000 | 141,915,000 | 6.09% | 0.01% |